Topical hemostatic agents in spinal surgery

Spinal surgery can be associated with significant intraoperative blood loss which may lead to various complications. As the number of patients undergoing spinal surgery increases over time, accurate and effective hemostasis becomes critically important. Despite various surgical hemostatic techniques...

Full description

Saved in:
Bibliographic Details
Published inThe spine journal Vol. 24; no. 6; pp. 933 - 946
Main Authors Shen, Feng, Ding, Jian, Wang, Yuelei, Yin, Chuqiang, Han, Zengshuai, Ren, Xianfeng, Li, Yanhui, Wang, Ting
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Spinal surgery can be associated with significant intraoperative blood loss which may lead to various complications. As the number of patients undergoing spinal surgery increases over time, accurate and effective hemostasis becomes critically important. Despite various surgical hemostatic techniques, conventional interventions such as compression, suture, ligation, and heat-generating cautery, are not suitable for osseous and epidural venous plexus bleeding during spinal procedures. Therefore, a variety of hemostatic agents have been developed to promote hemostasis. As they differ in terms of mechanism, form, application and potential adverse reactions, it is important to understand the natural features of existing agents. Here we comprehensively review currently available topical hemostatic agents from different sources and summarize their mechanisms of action, applications, and current or potential utilization in spinal surgery. We found hemostatic agents from different sources exert hemostatic actions through different mechanisms. In addition, topical hemostatic agents play various roles in spinal surgery including as hemostatic agent, dura mater repair, drug-carrier, skin closure, and fibrosis prevention. Compressive neurological complications are the most common complications of these hemostatic agents. Therefore, optimal use in spinal environments should match their features, indications, and efficacy with clinical conditions.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1529-9430
1878-1632
DOI:10.1016/j.spinee.2024.01.003